| Code | 6896C | ||||||||||
| MA number | 81/0039/18-S | ||||||||||
| Product Form: | tbl 8x25 µg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Norgine B.V., Netherland | ||||||||||
| Therapeutic Class: | 81 - UTEROTONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 02.02.2018 |
| SPC: |
SPC_Angusta_06_2021.pdf
|
| PIL: |
PIL_Angusta 25 mcg tbl_09_2025.pdf
|
| Safety feature | Yes |
| Data update: | 28.09.2021 |
